| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP And Gm Cell Therapy
1 company
Harris John David is a VP And Gm Cell Therapy at PLUS THERAPEUTICS, INC.. Recent SEC Form 4 filings include 2 buys and 0 sells.
Estimated insider holdings value: $43K based on current market prices.